2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the
Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients. | Semantic Scholar
Industry Sponsored Trials and Entresto in CHF - REBEL EM - Emergency Medicine Blog
A Critical Appraisal of Short-Term End Points in Acute Heart Failure Clinical Trials - Journal of Cardiac Failure
Heart Failure Management Innovation Enabled by Electronic Health Records - ScienceDirect
Multiple-Hospital Lean Initiative to Improve Congestive Heart Failure Care: A Mixed-Methods Evaluation | JSHIP
Timing and Duration of Interventions in Clinical Trials for Patients With Hospitalized Heart Failure | Circulation: Heart Failure
Developing a core outcome set on traditional Chinese medicine (COS-TCM) for chronic heart failure (CHF): a study protocol | BMJ Open
Using INTERMACS(IM) to Establish Objective Performance Criteria (OPC) for Clinical Trials in “Less Sick” Advanced CHF Patients: An Analysis of the STS IM Database - The Journal of Heart and Lung Transplantation
Comparison of the prognosis of patients with CHF between Western... | Download Scientific Diagram
Revolutionary implant could ease congestive heart failure - ISRAEL21c
AskBio initiates Phase I trial of gene therapy for heart failure
Endpoints in Heart Failure Drug Development: History and Future - ScienceDirect
EMPAKT CHF trial points to change in assessment acute heart failure patients
The WHICH? trial: rationale and design of a pragmatic randomized, multicentre comparison of home‐ vs. clinic‐based management of chronic heart failure patients - Stewart - 2011 - European Journal of Heart Failure -
Major pharmacotherapy of CHF and related clinical trials. | Download Scientific Diagram
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial - The Lancet
Heart failure with mid-range or mildly reduced ejection fraction | Nature Reviews Cardiology
Innovative Telemonitoring Enhanced Care Programme for Chronic Heart Failure (ITEC-CHF) to improve guideline compliance and collaborative care: protocol of a multicentre randomised controlled trial | BMJ Open
Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory - ScienceDirect
![Top 10 Congestive Heart Failure Clinical Trials [2022 Studies] | Power](https://pwr-og-img.withpower.com/Congestive%20Heart%20Failure%20research%20studies%20recruiting%20patients%20need%20your%20help.%20Receive%20premium%20care%20&%20cutting%20edge%20treatments%20by%20enrolling%20in%20congestive%20heart%20failure%20clinical%20trials%20today..png?md=1 "Top 10 Congestive Heart Failure Clinical Trials [2022 Studies] | Power")
Top 10 Congestive Heart Failure Clinical Trials [2022 Studies] | Power
Prognostic Significance of Longitudinal Clinical Congestion Pattern in Chronic Heart Failure: Insights From TIME-CHF Trial - The American Journal of Medicine
The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials | JACC: Heart Failure
Congestive Heart Failure - Several Promising Drugs are in Phase III Clinical Trials | Market Research Reports® Inc.
OPTIME CHF and PRAISE II: Recent heart failure trials Clinical Trial Commentary Dr Eric Topol Chairman and Professor, Department of Cardiology Director. - ppt download
![Top 10 Congestive Heart Failure Clinical Trials [2022 Studies] | Power](https://pwr-og-img.withpower.com/Apply%20to%20this%20Phase%20%3C%201%20clinical%20trial%20treating%20Heart%20Failure,%20Left%20Ventricular%20Hypertrophy,%20Infarction,%20Myocardial%20Infarction,%20Hypertrophy,%20Hypertrophy,%20Left%20Ventricular:%0A%0ATreatment%20for%20Heart%20Failure.png?md=1 "Top 10 Congestive Heart Failure Clinical Trials [2022 Studies] | Power")
Top 10 Congestive Heart Failure Clinical Trials [2022 Studies] | Power
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials - The Lancet
